Diprosalic

Land: Armenien

Språk: engelska

Källa: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktiva substanser:

betamethasone (betamethasone dipropionate), salicylic acid

Tillgänglig från:

Schering-Plough Labo N.V.

INN (International namn):

betamethasone (betamethasone dipropionate), salicylic acid

Dos:

0,5mg/g+30mg/g

Läkemedelsform:

ointment

Receptbelagda typ:

Prescription

Produktens egenskaper

1
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
DIPROSALIC
®
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ _
_GENERAL CHARACTERISTIC: _
_MAIN PHYSICAL/CHEMICAL PROPERTIES_: soft, homogeneous, white ointment
without foreign inclusions.
_COMPOSITION:_ 1 g of ointment contains betamethasone 0.5 mg (as
betamethasone dipropionate) and
salicylic acid 30 mg;
_EXCIPIENTS_: liquid paraffin, white soft paraffin.
3.
PHARMACEUTICAL FORM
Ointment.
PHARMACOTHERAPEUTIC GROUP. Dermatological corticosteroids. Active
corticosteroids in combination
with other agents. ATC code: D07X C01.
4.
CLINICAL PARTICULARS
_ _
4.1
THERAPEUTIC INDICATIONS
To relieve inflammations in the hyperkeratotic and dry dermatoses that
are normally responsive to
corticosteroid
therapy:
psoriasis,
chronic
atopic
dermatitis,
neurodermatitis
(lichen
simplex
chronicus), lichen planus, eczema (including nummular eczema, grocers
itch, eczematoid dermatitis),
dyshidrosis (dropsy), seborrheic dermatitis of the scalp, ichthyosis
vulgaris and other ichthyotic
conditions.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_ _
_Adults and children_: a thin film should be applied to cover the
affected area twice daily – in the
morning and in the evening. For some patients adequate maintenance
therapy may be achieved with
less frequent application. Duration of therapy varies depending upon
the severity and state of the
disease.
_Maximum daily dose_: the dose should be adjusted to have daily
control of symptoms.
4.3
CONTRAINDICATIONS
- Hypersensitivity to any of components of the preparation.
- Bacterial and viral infections of skin (herpes, varicella, herpes
zoster, molluscum contagiosum) or
fungal infection; tuberculosis, lues, skin post-vaccinal reactions.
- Acne vulgaris, acne, rosacea, perioral dermatitis.
Avoid contact with wounds, ulcers or mucosa.
Do not use Diprosalic in ophthalmology; do not use under occlusive
dressing.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If irritation or sensitisation develops with the use of the drug,
treatment sho